Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1996 Jun;223(6):747–756. doi: 10.1097/00000658-199606000-00013

Management of biliary tract stones in heart transplant patients.

M Milas 1, R R Ricketts 1, J R Amerson 1, K Kanter 1
PMCID: PMC1235225  PMID: 8645048

Abstract

OBJECTIVE: The authors report their experience with biliary tract stones in adult and pediatric heart transplant patients, and review the current literature relative to this problem. SUMMARY BACKGROUND DATA: Prior studies in adults have noted that heart transplant patients frequently have cholelithiasis, but offer no consensus about treatment strategy. Few studies exist for pediatric heart transplant patients. A higher rate of hemolysis and cyclosporine-induced changes in bile metabolism may contribute to lithogenesis in this population. METHODS: A chart review was conducted for 211 patients who had heart transplants between January 1988 and September 1994 to determine prevalence of biliary tract stones, management strategies used, and outcome. RESULTS: Of 175 long-term heart transplant survivors, 52 (29.7%) had stones detected: 32.8% of adults (47/143) and 15.6% of children (5/32). The majority of patients (31) were diagnosed 4 months (mean) after transplantation; cholelithiasis developed in 10 of these patients (32%) within 11 months (median) after a negative ultrasound. Symptoms developed in 45% of patients. All patients underwent either elective (36) or urgent (6) cholecystectomy via an open (32) or laparoscopic (10) approach, or endoscopy for common bile duct stones (2). There were no deaths or complications during a follow-up period of up to 7 years. CONCLUSION: Heart transplant patients have a high prevalence of symptomatic biliary tract stone disease. They can be treated safely via an open or laparoscopic approach after transplantation. The authors recommend routine gallbladder ultrasound screening and elective cholecystectomy in the post-transplant period if stones are detected.

Full text

PDF
753

Images in this article

753Figure 4.
on p.753

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrassy R. J., Treadwell T. A., Ratner I. A., Buckley C. J. Gallbladder disease in children and adolescents. Am J Surg. 1976 Jul;132(1):19–21. doi: 10.1016/0002-9610(76)90282-8. [DOI] [PubMed] [Google Scholar]
  2. Ballantyne C. M., Podet E. J., Patsch W. P., Harati Y., Appel V., Gotto A. M., Jr, Young J. B. Effects of cyclosporine therapy on plasma lipoprotein levels. JAMA. 1989 Jul 7;262(1):53–56. [PubMed] [Google Scholar]
  3. Begos D. G., Franco K. L., Baldwin J. C., Lee F. A., Revkin J. H., Modlin I. M. Optimal timing and indications for cholecystectomy in cardiac transplant patients. World J Surg. 1995 Jul-Aug;19(4):661–667. doi: 10.1007/BF00294752. [DOI] [PubMed] [Google Scholar]
  4. Boline G. B., Gifford R. R., Yang H. C., High K. M., Hensley F. A., Jr, Burg J. E., Wisman C. B. Cholecystectomy in the potential heart transplant patient. J Heart Lung Transplant. 1991 Mar-Apr;10(2):269–274. [PubMed] [Google Scholar]
  5. Carroll B. J., Chandra M., Phillips E. H., Harold J. G. Laparoscopic cholecystectomy in the heart transplant candidate with acute cholecystitis. J Heart Lung Transplant. 1992 Jul-Aug;11(4 Pt 1):831–833. [PubMed] [Google Scholar]
  6. Colon R., Frazier O. H., Kahan B. D., Radovancevic B., Duncan J. M., Lorber M. I., Van Buren C. T. Complications in cardiac transplant patients requiring general surgery. Surgery. 1988 Jan;103(1):32–38. [PubMed] [Google Scholar]
  7. Diehl A. K. Epidemiology and natural history of gallstone disease. Gastroenterol Clin North Am. 1991 Mar;20(1):1–19. [PubMed] [Google Scholar]
  8. Edwards B. D., Bhatnagar D., Mackness M. I., Gokal R., Ballardie F. W., Chalmers R. J., Durrington P. N. Effect of low-dose cyclosporin on plasma lipoproteins and markers of cholestasis in patients with psoriasis. QJM. 1995 Feb;88(2):109–113. [PubMed] [Google Scholar]
  9. Girardet R. E., Rosenbloom P., DeWeese B. M., Masri Z. H., Attum A. A., Barbie R. N., Yared S. F., Lusk R. A., Lansing A. M. Significance of asymptomatic biliary tract disease in heart transplant recipients. J Heart Transplant. 1989 Sep-Oct;8(5):391–399. [PubMed] [Google Scholar]
  10. Graham S. M., Flowers J. L., Schweitzer E., Bartlett S. T., Imbembo A. L. The utility of prophylactic laparoscopic cholecystectomy in transplant candidates. Am J Surg. 1995 Jan;169(1):44–49. doi: 10.1016/s0002-9610(99)80108-1. [DOI] [PubMed] [Google Scholar]
  11. Klintmalm G. B., Iwatsuki S., Starzl T. E. Cyclosporin A hepatotoxicity in 66 renal allograft recipients. Transplantation. 1981 Dec;32(6):488–489. doi: 10.1097/00007890-198112000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lorber M. I., Van Buren C. T., Flechner S. M., Williams C., Kahan B. D. Hepatobiliary and pancreatic complications of cyclosporine therapy in 466 renal transplant recipients. Transplantation. 1987 Jan;43(1):35–40. doi: 10.1097/00007890-198701000-00009. [DOI] [PubMed] [Google Scholar]
  13. Lorber M. I., Van Buren C. T., Flechner S. M., Williams C., Kahan B. D. Hepatobiliary complications of cyclosporine therapy following renal transplantation. Transplant Proc. 1987 Feb;19(1 Pt 2):1808–1810. [PubMed] [Google Scholar]
  14. Peterseim D. S., Pappas T. N., Meyers C. H., Shaeffer G. S., Meyers W. C., Van Trigt P. Management of biliary complications after heart transplantation. J Heart Lung Transplant. 1995 Jul-Aug;14(4):623–631. [PubMed] [Google Scholar]
  15. Queneau P. E., Bertault-Peres P., Guitaoui M., Mesdjian E., Durand A., Montet J. C. Improvement of cyclosporin A-induced cholestasis by tauroursodeoxycholate in a long-term study in the rat. Dig Dis Sci. 1994 Jul;39(7):1581–1585. doi: 10.1007/BF02088068. [DOI] [PubMed] [Google Scholar]
  16. Sekela M. E., Hutchins D. A., Young J. B., Noon G. P. Biliary surgery after cardiac transplantation. Arch Surg. 1991 May;126(5):571–573. doi: 10.1001/archsurg.1991.01410290043009. [DOI] [PubMed] [Google Scholar]
  17. Spes C. H., Angermann C. E., Beyer R. W., Schreiner J., Lehnert P., Kemkes B. M., Theisen K. Increased incidence of cholelithiasis in heart transplant recipients receiving cyclosporine therapy. J Heart Transplant. 1990 Jul-Aug;9(4):404–407. [PubMed] [Google Scholar]
  18. Steck T. B., Costanzo-Nordin M. R., Keshavarzian A. Prevalence and management of cholelithiasis in heart transplant patients. J Heart Lung Transplant. 1991 Nov-Dec;10(6):1029–1032. [PubMed] [Google Scholar]
  19. Stone B., Warty V., Dindzans V., Van Thiel D. The mechanism of cyclosporine-induced cholestasis in the rat. Transplant Proc. 1988 Jun;20(3 Suppl 3):841–844. [PubMed] [Google Scholar]
  20. Villar H. V., Neal D. D., Levinson M., Fuller J. M., Emery R. W., Graham A. R., Copeland J., Rhenman M. J., Copeland J. G. Gastrointestinal complications after human transplantation and mechanical heart replacement. Am J Surg. 1989 Jan;157(1):168–174. doi: 10.1016/0002-9610(89)90441-8. [DOI] [PubMed] [Google Scholar]
  21. Weinstein S., Lipsitz E. C., Addonizio L., Stolar C. J. Cholelithiasis in pediatric cardiac transplant patients on cyclosporine. J Pediatr Surg. 1995 Jan;30(1):61–64. doi: 10.1016/0022-3468(95)90611-8. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES